Showing results (511-520 of 887) with videos related to
Sort By:
Pageof 89
Parkinson'S Disease|July 4, 2020
Validation of Parkinson's Disease-Related Questionnaires in South AfricaGill Nelson, Ntombizodwa Ndlovu, Nicola Christofides, et al.Parkinson'S Disease|March 28, 2013
Slow Down and Concentrate: Time for a Paradigm Shift in Fall Prevention among People with Parkinson's Disease?Emma L Stack, Helen C RobertsParkinson'S Disease|May 9, 2012
Dopamine agonists and pathologic behaviorsBrendan J Kelley, Andrew P Duker, Peter ChiuParkinson'S Disease|May 12, 2012
Metacognitive Performance, the Tip-of-Tongue Experience, Is Not Disrupted in Parkinsonian PatientsJustin D Oh-Lee, Sarah M Szymkowicz, Stefanie L Smith, et al.Parkinson'S Disease|April 13, 2012
Are verbal fluency and nonliteral language comprehension deficits related to depressive symptoms in Parkinson's disease?Christina Tremblay, Oury Monchi, Carol Hudon, et al.Parkinson'S Disease|April 13, 2012
Dyskinesias and treatment with pramipexole in patients with Parkinson's diseaseJohn C P Piedad, Andrea E CavannaParkinson'S Disease|May 3, 2012
Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-SynucleinopathiesKazunari Sekiyama, Shuei Sugama, Masayo Fujita, et al.Parkinson'S Disease|April 25, 2012
Web-based assessment of visual and visuospatial symptoms in Parkinson's diseaseMelissa M Amick, Ivy N Miller, Sandy Neargarder, et al.Parkinson'S Disease|December 23, 2011
The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation projectVinod Metta, Kartik Logishetty, P Martinez-Martin, et al.Parkinson'S Disease|December 23, 2011
Adenosine A(2A) Receptor Antagonists Do Not Disrupt Rodent Prepulse Inhibition: An Improved Side Effect Profile in the Treatment of Parkinson's DiseaseCarina J Bleickardt, Abigail L Lashomb, Carrie E Merkel, et al.Pageof 89